“…23,24 Consequently, upregulated folate receptor (FR) expression and the key role of FA in a wide spectrum of cancers make it an ideal biomarker for targeted therapy. [25][26][27] In previous reports, numerous modications have been developed to improve the biocompatibility and the chemotherapeutic delivery of GO; 28 this includes the use of polymeric modiers, such as polyethylene glycol, [29][30][31] Poloxamer, 32-34 poly(amido amine), 35 poly(N-isopropyl acrylamide), 36 chitosan, 37,38 heparin, 39 and gelatin, 40,41 while the employed chemotherapeutics have included doxorubicin (DOX) and derivatives, 29,33,35,39 paclitaxel, 42 camptothecin, 36,37 and even methotrexate. 41 The reported drug loading capacity in the mass percentage ranged from 5% to 380%.…”